Top Markets
Coin of the day
Pharmosa Biopharm Inc. Pharmosa Biopharm Inc.

Pharmosa Biopharm Inc.

6875
Clasificación en acciones #20403
Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in... Pharmosa Biopharm Inc., a biotechnology firm based in Taiwan, specializes in the development of pharmaceutical products. Its current pipeline includes two key candidates: L606 and L608. L606 is an investigational inhalation/device combination therapy designed to treat both pulmonary arterial hypertension and pulmonary hypertension linked to interstitial lung disease. Similarly, L608 is another inhalation-based therapy, paired with a device, aimed at addressing pulmonary vascular disease. The company, which was established in 2000, originally operated under the name Pharmosa Limited before adopting its current name, Pharmosa Biopharm Inc., in October 2016. Its main offices are located in Taipei City, Taiwan.
Precio por acción
$1.02
Capitalización bursátil
$131.45M
Cambio (1 día)
-0.62%
Cambio (1 año)
-37.92%
País
TW
Comercio Pharmosa Biopharm Inc. (6875)

Categoría

Historial de rendimiento por dividendo de Pharmosa Biopharm Inc. (6875)
Rendimiento por dividendo (TTM) de Pharmosa Biopharm Inc. (símbolo bursátil: 6875) al 2026: 0
Rendimiento promedio por dividendo de los últimos 5 años: 0.00%
Historial de rendimiento por dividendo de Pharmosa Biopharm Inc. (6875) desde 2026 hasta 2026
Rendimiento por dividendo al final de cada año (TTM)
Año Rendimiento por dividendo Cambiar
Not enough data for the provided dates.
Rendimientos por dividendo (TTM) de empresas similares o competidoras
Empresa Rendimiento por dividendo País
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH